AKT1 and cancer: The main differences between subtypes were immune response processes (immune response and immune effector process, etc.), metabolic states (metabolism of xenobiotics by cytochrome P450, etc.), as well as cancer-related signaling pathways (P53 and PI3K-Akt signaling pathway, etc.)(Figure 4A).